• There is significant regional variation within Africa in cervical cancer incidence
HPV Carcinogenesis
• Persistent infection with hrHPV infection occurs in only 4 -12%
• There is little data on prevalence of persistence and its determinants in African populations
• hrHPV infection leads to progressive changes in the cervical epithelium that can be detected before frank malignancy
• Estimated absolute risk for CIN3+ • 47.4% (95% CI = 34.9% to 57.5%) • > 12 years of follow up after 2 positive qualitative type specific hrHPV • Estimated absolute risk for CIN3+ or worse 3.0% (95% CI = 2.5% to 3.5%)
• following a qualitative hrHPV test
Epidemiology of HPV Infection
Pattern of HPV infections in Nigerian women
• We studied 278 women enrolled in cervical cancer screening programs at 2 sites in Abuja, Nigeria
• Among HIV+ women, HPV35 (8.7%) and HPV56 (7.4%) were the most prevalent hrHPV types, while HPV52 and HPV68 (2.8%, each) were the most prevalent among HIV-women
• HIV infection was associated with increased risk of any HPV, hrHPV and multiple HPV infections.
High risk HPV in HIV+ and HIV-women
• The multivariate prevalence ratio for any hrHPV and multiple hrHPV were 4.18 (95% CI 2.05 -8.49, p-value <0.0001) and 6.6 (95% CI 1.49 -29.64, p-value 0.01) respectively, comparing HIV+ to HIV-women
• Oncogenic HPV types 35, 52, 56 and 68 may be more important risk factors for cervical pre-cancer and cancer among women in Africa. Current HPV vaccines do not cover the prevalent hrHPV types in this population and degree of cross reactivity of the vaccine needs to be ascertained. Genomic risk of prevalent hrHPV infection in Nigerian women
• Sgnificant associations with 2 SNPs -rs2305809 on Ribosomal Protein gene S19 (RPS19) and rs2342700 on Thymidylate Synthase gene (TYMS)and prevalent hrHPV infection. • Genes/regions in the immune genes 2',5' oligoadenylate synthetase gene 3 (OAS3), sulfatase 1 (SULF1), epidermal dysplasia verruciformis (EV)associated EVER1 and EVER2 genes, transmembrane channel-like 6 and 8 (TMC6, TMC8), peroxiredoxin 3 (PRDX3), interleukin 2 receptorα (IL2RA), telomere maintenance 2 (TELO2), and complement component 1, r subcomponent-like (C1RL) were not associated. • RPS19 gene codes for a ribosomal protein expressed by hematopoietic and non-hematopoietic tissues while TYMS gene product is used in the DNA synthesis and repair pathway. 
Epigenetics of HPV infection

Epigenetics of HPV
EPB41L3 Reproducibility
Current ACCME research -Epidemiology and carcinogenesis of hrHPV 5a. For Project 1 (prevalence of hrHPV) -select 800 controls without persistent hrHPV infection from 3b. 5b. For Project 2 (cervical cytokine study) -Randomly select 320 controls without persistent hrHPV from 3b. 5c. For Project 2 (vaginal microbiome) Randomly select 75 controls with cervical cytokines results but no persistent hrHPV For Project 3 (Candidate gene association studies) -640 women with cervical cytokines results (from 4b and 5b) and 150 women with vaginal microbiome results will be allocated into categories depending on the results of their specific analysis and their association with specific SNPs tested 4d. For Project 3 (GWAS) the germline DNA of the 800 cases with persistent hrHPV infection in 4a are used 5d. For Project 3 (GWAS) -All 13,500 controls are enrolled
